CIPP Rett Centre

 

The CIPP Rett Centre is a clinical treatment and research centre for children and adults with Rett Syndrome and related disorders of all ages.

Based at King’s College Hospital, the Centre monitors children and adults with Rett Syndrome and related disorders nationally through the CIPP Rett Database and conducts clinical trials.

The CIPP Rett Centre accepts referrals from a variety of sources. These include Consultants from various specialities (including paediatricians and neurologists), GPs, patient organisations and self-referrals. To refer a patient to the CIPP Rett Centre, email: [email protected] or contact [email protected] for more info.

CIPP Rett Centre intervention is based on a holistic multi-modal approach. As part of the referral process, parents/carers will be asked to complete a battery of online questionnaires which will inform the acceptance and prioritisation of the referral. Local services are expected to be either involved or be willing to work within a Shared Care Protocol in order to optimise outcomes quickly.

 

CIPP Rett Database

The CIPP Rett Database is an online system through which the CIPP Rett team are able to monitor the well-being of UK patients with Rett Syndrome and related disorders at a distance.

Being part of the CIPP Rett Database is also a way of helping with efforts to bring about treatments for Rett Syndrome.

The more patients who are on the database, the more information the team is able to gather about Rett Syndrome, how it affects UK patients and the need for treatment.

You can add your child or adult with Rett Syndrome to the CIPP Rett Database by emailing: [email protected].

    Contact Details


     

    Any enquiries, please email [email protected]

    Latest news

    View: All
    • Charities urged to check fundraisers’ credentials due to Pudsey scammer

      Charities urged to check fundraisers’ credentials due to Pudsey scammer

      Charities have been in the news this week, due to the unscrupulous acts of
      Read More
    • Taysha receives go-ahead for early dose escalation in adolescent and adult Rett syndrome gene therapy trial 

      Taysha receives go-ahead for early dose escalation in adolescent and adult Rett syndrome gene therapy trial 

      Yesterday, 19th March 2024, Taysha Gene Therapies published a press release with an update
      Read More
    • Scoliosis in Rett syndrome: Repeat cancellations of essential operations in UK as a safeguarding concern.

      Scoliosis in Rett syndrome: Repeat cancellations of essential operations in UK as a safeguarding concern.

      This article may be a difficult read for young or newly diagnosed families but
      Read More